Research graph
References from Neurofibrillary tangle deposition in primary idiotypic isocortices using flortaucipir PET in histopathologically confirmed Alzheimer’s disease. Local targets link to admitted publications; unresolved targets remain external evidence.
Alzheimer's disease
10.1038/nrdp.2015.56 · 2015 · External reference
Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years
10.1097/nen.0b013e318232a379 · 2011 · External reference
The Ultrastructure of the Neurofibrillary Tangle and the Senile Plaque
1970 · External reference
The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
10.1016/j.jalz.2011.03.005 · 2011 · External reference
Hippocampal excitatory amino acid receptors in elderly, normal individuals and those with Alzheimer's disease: non-N-methyl-D-aspartate receptors
10.1016/0306-4522(92)90379-g · 1992 · External reference
Focal cortical presentations of Alzheimer's disease
10.1093/brain/awm213 · 2007 · External reference
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
10.1016/s1474-4422(14)70090-0 · 2014 · External reference
New insights into atypical Alzheimer's disease in the era of biomarkers
10.1016/s1474-4422(20)30440-3 · 2021 · External reference
Alzheimer's disease clinical variants show distinct regional patterns of neurofibrillary tangle accumulation
10.1007/s00401-019-02036-6 · 2019 · External reference
Four distinct trajectories of tau deposition identified in Alzheimer's disease
10.1038/s41591-021-01309-6 · 2021 · External reference
[(18) F]AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease
10.1002/ana.25142 · 2018 · External reference
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
10.1212/wnl.41.4.479 · 1991 · External reference
Diagnosis of Alzheimer's disease
10.1001/archneur.1985.04060100083029 · 1985 · External reference
Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease
1997 · External reference
Phases of A beta-deposition in the human brain and its relevance for the development of AD
10.1212/wnl.58.12.1791 · 2002 · External reference
Neuropathological stageing of Alzheimer-related changes
10.1007/bf00308809 · 1991 · External reference
Diagnostic criteria for neuropathologic assessment of Alzheimer's disease
10.1016/s0197-4580(97)00062-6 · 1997 · External reference
Frequency of stages of Alzheimer-related lesions in different age categories
10.1016/s0197-4580(97)00056-0 · 1997 · External reference
From sensation to cognition
10.1093/brain/121.6.1013 · 1998 · External reference
The Human Brainnetome Atlas: A New Brain Atlas Based on Connectional Architecture
10.1093/cercor/bhw157 · 2016 · External reference
Defined neurofilament, tau, and beta-amyloid precursor protein epitopes distinguish Alzheimer from non-Alzheimer senile plaques
10.1073/pnas.87.6.2249 · 1990 · External reference
Molecular neuropathology of Alzheimer's disease: in situ hybridization studies
10.1007/bf00733642 · 1990 · External reference
[(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease
10.1016/j.jalz.2012.11.008 · 2013 · External reference
In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (florbetapir [corrected] F 18)
10.2967/jnumed.109.069088 · 2010 · External reference
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
10.1002/ana.20009 · 2004 · External reference
PET of brain amyloid and tau in mild cognitive impairment
10.1056/nejmoa054625 · 2006 · External reference
Discovery and preclinical characterization of [(18)F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies
10.1007/s00259-019-04397-2 · 2019 · External reference
Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles
10.2967/jnumed.115.171678 · 2016 · External reference
An autoradiographic evaluation of AV-1451 Tau PET in dementia
10.1186/s40478-016-0315-6 · 2016 · External reference
[F-18]-AV-1451 binding correlates with postmortem neurofibrillary tangle Braak staging
10.1007/s00401-017-1740-8 · 2017 · External reference
Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias
10.1016/j.jalz.2016.01.003 · 2016 · External reference
Sensitivity-Specificity of Tau and Amyloid β Positron Emission Tomography in Frontotemporal Lobar Degeneration
10.1002/ana.25893 · 2020 · External reference
Flortaucipir PET uncovers relationships between tau and amyloid-beta in primary age-related tauopathy and Alzheimer's disease
10.1126/scitranslmed.ado8076 · 2024 · External reference
Association of in vivo retention of [(18)f] flortaucipir pet with tau neuropathology in corresponding brain regions
10.1007/s00401-024-02801-2 · 2024 · External reference
Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes
10.1001/jamaneurol.2020.0528 · 2020 · External reference
18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases
10.1093/brain/awaa276 · 2020 · External reference
Investigating the feasibility of (18)F-flortaucipir PET imaging in the antemortem diagnosis of primary age-related tauopathy (PART): An observational imaging-pathological study
10.1002/alz.14301 · 2024 · External reference
Identifying early changes in imaging, plasma, and digital cognitive biomarkers that correspond to Alzheimer's disease pathology in the presence of autopsy-confirmed co-pathologies
10.1002/alz.71092 · 2026 · External reference
Association of [(18)F]Flortaucipir-PET and Plasma p-Tau217 With Tau Neuropathology in Alzheimer Disease and Other Neurodegenerative Disorders
10.1212/wnl.0000000000214576 · 2026 · External reference
Optimum Differentiation of Frontotemporal Lobar Degeneration from Alzheimer Disease Achieved with Cross-Sectional Tau Positron Emission Tomography
10.1002/ana.26479 · 2022 · External reference
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach
10.1007/s00401-011-0910-3 · 2012 · External reference
Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration
10.1007/s00401-007-0237-2 · 2007 · External reference
Tau positron emission tomographic imaging in aging and early Alzheimer disease
10.1002/ana.24546 · 2016 · External reference
PET Imaging of Tau Deposition in the Aging Human Brain
10.1016/j.neuron.2016.01.028 · 2016 · External reference
Distinct binding of PET ligands PBB3 and AV-1451 to tau fibril strains in neurodegenerative tauopathies
2017 · External reference
Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices
10.1523/jneurosci.07-06-01799.1987 · 1987 · External reference
Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease
10.1073/pnas.82.13.4531 · 1985 · External reference
Apical dendrite degeneration, a novel cellular pathology for Betz cells in ALS
10.1038/srep41765 · 2017 · External reference
Transmission and spreading of tauopathy in transgenic mouse brain
10.1038/ncb1901 · 2009 · External reference
Widespread tau seeding activity at early Braak stages
10.1007/s00401-016-1644-z · 2017 · External reference
The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases
10.1016/0168-0102(92)90014-4 · 1992 · External reference
Clinically concordant variations of Alzheimer pathology in aphasic versus amnestic dementia
10.1093/brain/aws076 · 2012 · External reference
In vivo Patterns of Tau Pathology, Amyloid-beta Burden, and Neuronal Dysfunction in Clinical Variants of Alzheimer's Disease
10.3233/jad-160316 · 2017 · External reference
MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous
10.1002/acn3.51038 · 2020 · External reference
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease
10.1093/brain/aww027 · 2016 · External reference
Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes
10.1093/brain/awaa155 · 2020 · External reference
Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition
2017 · External reference
The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer's disease
10.1016/j.jalz.2018.12.016 · 2019 · External reference
AV-1451 tau and beta-amyloid positron emission tomography imaging in dementia with Lewy bodies
10.1002/ana.24825 · 2017 · External reference
Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases
10.1002/mds.27252 · 2018 · External reference
Is the pathology of posterior cortical atrophy clinically predictable?
10.1515/revneuro-2022-0003 · 2022 · External reference
Motor features in posterior cortical atrophy and their imaging correlates
10.1016/j.neurobiolaging.2014.05.028 · 2014 · External reference
Longitudinal tau-PET uptake and atrophy in atypical Alzheimer's disease
10.1016/j.nicl.2019.101823 · 2019 · External reference
Longitudinal tau PET in ageing and Alzheimer's disease
10.1093/brain/awy059 · 2018 · External reference
The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects
10.1093/brain/awaa327 · 2020 · External reference
Sex Differences in Longitudinal Tau-PET in Preclinical Alzheimer Disease: A Meta-Analysis
10.1001/jamaneurol.2025.0013 · 2025 · External reference
Sex differences in the association of Alzheimer's disease biomarkers and cognition in a multicenter memory clinic study
10.1186/s13195-025-01684-z · 2025 · External reference
Sex-specific modulation of amyloid-beta on tau phosphorylation underlies faster tangle accumulation in females
10.1093/brain/awad397 · 2024 · External reference
Sex and APOE epsilon4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease
2023 · External reference
Menopause Status Moderates Sex Differences in Tau Burden: A Framingham PET Study
10.1002/ana.26382 · 2022 · External reference
APOE epsilon4 influences medial temporal atrophy and tau deposition in atypical Alzheimer's disease
10.1002/alz.12711 · 2023 · External reference
Association of APOE4 and Clinical Variability in Alzheimer Disease With the Pattern of Tau- and Amyloid-PET
10.1212/wnl.0000000000011270 · 2021 · External reference
Effect of APOE epsilon4 genotype on amyloid-beta and tau accumulation in Alzheimer's disease
10.1186/s13195-020-00710-6 · 2020 · External reference
APOE effects on regional tau in preclinical Alzheimer's disease
10.1186/s13024-022-00590-4 · 2023 · External reference
Data-driven decomposition and staging of flortaucipir uptake in Alzheimer's disease
10.1002/alz.13769 · 2024 · External reference
The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics
10.1159/000115751 · 2008 · External reference
“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
10.1016/0022-3956(75)90026-6 · 1975 · External reference
A new clinical scale for the staging of dementia
10.1192/bjp.140.6.566 · 1982 · External reference
Mild cognitive impairment as a diagnostic entity
10.1111/j.1365-2796.2004.01388.x · 2004 · External reference
Consensus classification of posterior cortical atrophy
10.1016/j.jalz.2017.01.014 · 2017 · External reference
The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features
10.1093/brain/awv191 · 2015 · External reference
Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium
10.1212/wnl.0000000000004058 · 2017 · External reference
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop
10.1212/wnl.43.2.250 · 1993 · External reference
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
10.1093/brain/awr179 · 2011 · External reference
Classification of primary progressive aphasia and its variants
10.1212/wnl.0b013e31821103e6 · 2011 · External reference
Primary progressive aphasia--differentiation from Alzheimer's disease
10.1002/ana.410220414 · 1987 · External reference
Criteria for the diagnosis of corticobasal degeneration
10.1212/wnl.0b013e31827f0fd1 · 2013 · External reference
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
10.1002/mds.26987 · 2017 · External reference
Single-day apolipoprotein E genotyping
10.1016/0165-0270(94)90168-6 · 1994 · External reference
National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease
10.1016/j.jalz.2011.10.007 · 2012 · External reference
A harmonized classification system for FTLD-TDP pathology
10.1007/s00401-011-0845-8 · 2011 · External reference
Unresolved reference
2017 · External reference
brms: An R Package for Bayesian Multilevel Models Using Stan
10.18637/jss.v080.i01 · 2017 · External reference
